BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 32434041)

  • 1. A Signature That May Be Predictive of Early Versus Late Recurrence After Radiation Treatment for Breast Cancer That May Inform the Biology of Early, Aggressive Recurrences.
    Speers C; Chang SL; Pesch A; Ritter C; Olsen E; Chandler B; Moubadder L; Liu M; Cameron M; Michmerhuizen A; Wilder-Romans K; Zhao SG; Nyati S; Bartelink H; Feng FY; Pierce LJ
    Int J Radiat Oncol Biol Phys; 2020 Nov; 108(3):686-696. PubMed ID: 32434041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of single-sample breast cancer radiosensitivity gene expression predictors.
    Sjöström M; Staaf J; Edén P; Wärnberg F; Bergh J; Malmström P; Fernö M; Niméus E; Fredriksson I
    Breast Cancer Res; 2018 Jul; 20(1):64. PubMed ID: 29973242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and Validation of a Novel Radiosensitivity Signature in Human Breast Cancer.
    Speers C; Zhao S; Liu M; Bartelink H; Pierce LJ; Feng FY
    Clin Cancer Res; 2015 Aug; 21(16):3667-77. PubMed ID: 25904749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local recurrences and distant metastases after breast-conserving surgery and radiation therapy for early breast cancer.
    Touboul E; Buffat L; Belkacémi Y; Lefranc JP; Uzan S; Lhuillier P; Faivre C; Huart J; Lotz JP; Antoine M; Pène F; Blondon J; Izrael V; Laugier A; Schlienger M; Housset M
    Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):25-38. PubMed ID: 9989511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and Validation of a Genomic Profile for the Omission of Local Adjuvant Radiation in Breast Cancer.
    Sjöström M; Fyles A; Liu FF; McCready D; Shi W; Rey-McIntyre K; Chang SL; Feng FY; Speers CW; Pierce LJ; Holmberg E; Fernö M; Malmström P; Karlsson P
    J Clin Oncol; 2023 Mar; 41(8):1533-1540. PubMed ID: 36599119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer.
    Gee HE; Buffa FM; Harris AL; Toohey JM; Carroll SL; Cooper CL; Beith J; McNeil C; Carmalt H; Mak C; Warrier S; Holliday A; Selinger C; Beckers R; Kennedy C; Graham P; Swarbrick A; Millar EK; O'Toole SA; Molloy T
    Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1104-14. PubMed ID: 26581147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.
    Mittempergher L; Saghatchian M; Wolf DM; Michiels S; Canisius S; Dessen P; Delaloge S; Lazar V; Benz SC; Tursz T; Bernards R; van't Veer LJ
    Mol Oncol; 2013 Oct; 7(5):987-99. PubMed ID: 23910573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting a local recurrence after breast-conserving therapy by gene expression profiling.
    Nuyten DS; Kreike B; Hart AA; Chi JT; Sneddon JB; Wessels LF; Peterse HJ; Bartelink H; Brown PO; Chang HY; van de Vijver MJ
    Breast Cancer Res; 2006; 8(5):R62. PubMed ID: 17069664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
    Drukker CA; Elias SG; Nijenhuis MV; Wesseling J; Bartelink H; Elkhuizen P; Fowble B; Whitworth PW; Patel RR; de Snoo FA; van 't Veer LJ; Beitsch PD; Rutgers EJ
    Breast Cancer Res Treat; 2014 Dec; 148(3):599-613. PubMed ID: 25414025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A microRNA signature associated with early recurrence in breast cancer.
    Pérez-Rivas LG; Jerez JM; Carmona R; de Luque V; Vicioso L; Claros MG; Viguera E; Pajares B; Sánchez A; Ribelles N; Alba E; Lozano J
    PLoS One; 2014; 9(3):e91884. PubMed ID: 24632820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of 21-Gene Recurrence Score in Predicting Prognostic Benefit of Radiation Therapy After Breast-Conserving Surgery for T1N0 Breast Cancer.
    Chevli N; Haque W; Tran KT; Farach AM; Schwartz MR; Hatch SS; Butler EB; Teh BS
    Pract Radiat Oncol; 2023; 13(3):e230-e238. PubMed ID: 36038115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
    Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
    Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local-regional control in breast cancer patients with a possible genetic predisposition.
    Freedman LM; Buchholz TA; Thames HD; Strom EA; McNeese MD; Hortobagyi GN; Singletary SE; Heaton KM; Hunt KK
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):951-7. PubMed ID: 11072150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling in primary breast cancer distinguishes patients developing local recurrence after breast-conservation surgery, with or without postoperative radiotherapy.
    Niméus-Malmström E; Krogh M; Malmström P; Strand C; Fredriksson I; Karlsson P; Nordenskjöld B; Stål O; Ostberg G; Peterson C; Fernö M
    Breast Cancer Res; 2008; 10(2):R34. PubMed ID: 18430221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer.
    Woodward WA; Barlow WE; Jagsi R; Buchholz TA; Shak S; Baehner F; Whelan TJ; Davidson NE; Ingle JN; King TA; Ravdin PM; Osborne CK; Tripathy D; Livingston RB; Gralow JR; Hortobagyi GN; Hayes DF; Albain KS
    JAMA Oncol; 2020 Apr; 6(4):505-511. PubMed ID: 31917424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of factors related to periods to ipsilateral breast tumor recurrence after breast-conserving surgery and measures for preventing recurrence in early breast cancer.
    Nishimura R; Akizuki M; Tashima R; Ootao R
    Breast Cancer; 2006; 13(2):152-8. PubMed ID: 16755110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration of a Radiosensitivity Molecular Signature Into the Assessment of Local Recurrence Risk in Breast Cancer.
    Torres-Roca JF; Fulp WJ; Caudell JJ; Servant N; Bollet MA; van de Vijver M; Naghavi AO; Harris EE; Eschrich SA
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(3):631-8. PubMed ID: 26461005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating patterns of utilization of gene signature panels and impact on treatment patterns in patients with ductal carcinoma in situ of the breast.
    Bhutiani N; Vuong B; Egger ME; Eldredge-Hindy H; McMasters KM; Ajkay N
    Surgery; 2019 Oct; 166(4):509-514. PubMed ID: 31337506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events.
    Veronesi U; Marubini E; Del Vecchio M; Manzari A; Andreola S; Greco M; Luini A; Merson M; Saccozzi R; Rilke F
    J Natl Cancer Inst; 1995 Jan; 87(1):19-27. PubMed ID: 7666458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.